Furthermore, independently of the quantitative levels, the MCP-4/MCP-1 ratio in CSF does not significantly discriminate between PTSD and healthy control patients, as it does in the 0200 or 0900 hours plasma samples. This evidence concerns the gene CCL13 and post-traumatic stress disorder.